CLOPIXOL ACTION PROLONGEE 200 mg/1 ml, solution for injection i.m. ampoule, 1 ml
Active ingredients: ZUCLOPENTHIXOL (DÉCANOATE DE)
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionampoule, 1 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLOPIXOL ACTION PROLONGEE 200 mg/1 ml, solution injectable I.M.
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- BB FARMA (ITALIE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Dec 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68072846CIP74900376CIP133400949003761Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ZUCLOPENTHIXOL (DÉCANOATE DE)solution | 200 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.